Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russel J Schilder

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Gynecologic Oncology|October 13, 2006
Relevant molecular markers and targetsKathleen M Darcy, Russel J Schilder
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 18, 2010
Sorafenib in combination with gemcitabine in recurrent epithelial ovarian cancer: a study of the Princess Margaret Hospital Phase II ConsortiumStephen A Welch, Hal W Hirte, Laurie Elit, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Gynecologic Oncology|October 13, 2006
Relevant molecular markers and targetsKathleen M Darcy, Russel J Schilder
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 18, 2010
Sorafenib in combination with gemcitabine in recurrent epithelial ovarian cancer: a study of the Princess Margaret Hospital Phase II ConsortiumStephen A Welch, Hal W Hirte, Laurie Elit, et al.
Pageof 1